Screening for Mild Cognitive Impairment in Parkinson’s Disease: Comparison of the Italian Versions of Three Neuropsychological Tests

Mild cognitive impairment (MCI) is frequent in Parkinson’s disease (PD). Recently proposed criteria for MCI in PD (PD-MCI) indicate level I diagnosis based on abbreviated assessment and level II based on comprehensive neuropsychological evaluation. The study explored the sensitivity and specificity...

Full description

Saved in:
Bibliographic Details
Main Authors: Angela Federico, Alice Maier, Greta Vianello, Daniela Mapelli, Michela Trentin, Giampietro Zanette, Alessandro Picelli, Marialuisa Gandolfi, Stefano Tamburin
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Parkinson's Disease
Online Access:http://dx.doi.org/10.1155/2015/681976
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850160365592117248
author Angela Federico
Alice Maier
Greta Vianello
Daniela Mapelli
Michela Trentin
Giampietro Zanette
Alessandro Picelli
Marialuisa Gandolfi
Stefano Tamburin
author_facet Angela Federico
Alice Maier
Greta Vianello
Daniela Mapelli
Michela Trentin
Giampietro Zanette
Alessandro Picelli
Marialuisa Gandolfi
Stefano Tamburin
author_sort Angela Federico
collection DOAJ
description Mild cognitive impairment (MCI) is frequent in Parkinson’s disease (PD). Recently proposed criteria for MCI in PD (PD-MCI) indicate level I diagnosis based on abbreviated assessment and level II based on comprehensive neuropsychological evaluation. The study explored the sensitivity and specificity of the Italian versions of three neuropsychological tests for level I diagnosis of PD-MCI. We recruited 100 consecutive PD patients. After screening for inclusion criteria, 43 patients were included. The sensitivity and specificity of the Mini Mental State Examination (MMSE), the Montreal Cognitive Assessment (MoCA), and the Addenbrooke’s Cognitive Examination Revised (ACE-R) in comparison to level II diagnosis of PD-MCI were examined. PD-MCI was diagnosed (level II) in 51% of patients. Disease duration was significantly longer and PD motor scales were more severely impaired in MCI group. The receiver-operator characteristics curve documented nonsignificant difference in the performance of the three tests, with slight advantage of MMSE (corrected data). The time of administration favored MMSE. In Italian-speaking PD patients, MMSE might represent a good screening tool for PD-MCI, because of the shorter time of administration and the performance comparable to those of MoCA and ACE-R. Further studies are needed to validate the new PD-MCI criteria across different languages and cultures.
format Article
id doaj-art-b6f8cf92589e42ef95b32b4ecfc8f197
institution OA Journals
issn 2090-8083
2042-0080
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Parkinson's Disease
spelling doaj-art-b6f8cf92589e42ef95b32b4ecfc8f1972025-08-20T02:23:09ZengWileyParkinson's Disease2090-80832042-00802015-01-01201510.1155/2015/681976681976Screening for Mild Cognitive Impairment in Parkinson’s Disease: Comparison of the Italian Versions of Three Neuropsychological TestsAngela Federico0Alice Maier1Greta Vianello2Daniela Mapelli3Michela Trentin4Giampietro Zanette5Alessandro Picelli6Marialuisa Gandolfi7Stefano Tamburin8Department of Neurological and Movement Sciences, University of Verona, Piazzale Scuro 10, 37134 Verona, ItalyDepartment of Neurological and Movement Sciences, University of Verona, Piazzale Scuro 10, 37134 Verona, ItalyDepartment of General Psychology, University of Padova, Via Venezia 8, 35100 Padua, ItalyDepartment of General Psychology, University of Padova, Via Venezia 8, 35100 Padua, ItalyNeurology Unit Pederzoli Hospital, Via Monte Baldo 24, 37019 Peschiera del Garda, ItalyNeurology Unit Pederzoli Hospital, Via Monte Baldo 24, 37019 Peschiera del Garda, ItalyDepartment of Neurological and Movement Sciences, University of Verona, Piazzale Scuro 10, 37134 Verona, ItalyDepartment of Neurological and Movement Sciences, University of Verona, Piazzale Scuro 10, 37134 Verona, ItalyDepartment of Neurological and Movement Sciences, University of Verona, Piazzale Scuro 10, 37134 Verona, ItalyMild cognitive impairment (MCI) is frequent in Parkinson’s disease (PD). Recently proposed criteria for MCI in PD (PD-MCI) indicate level I diagnosis based on abbreviated assessment and level II based on comprehensive neuropsychological evaluation. The study explored the sensitivity and specificity of the Italian versions of three neuropsychological tests for level I diagnosis of PD-MCI. We recruited 100 consecutive PD patients. After screening for inclusion criteria, 43 patients were included. The sensitivity and specificity of the Mini Mental State Examination (MMSE), the Montreal Cognitive Assessment (MoCA), and the Addenbrooke’s Cognitive Examination Revised (ACE-R) in comparison to level II diagnosis of PD-MCI were examined. PD-MCI was diagnosed (level II) in 51% of patients. Disease duration was significantly longer and PD motor scales were more severely impaired in MCI group. The receiver-operator characteristics curve documented nonsignificant difference in the performance of the three tests, with slight advantage of MMSE (corrected data). The time of administration favored MMSE. In Italian-speaking PD patients, MMSE might represent a good screening tool for PD-MCI, because of the shorter time of administration and the performance comparable to those of MoCA and ACE-R. Further studies are needed to validate the new PD-MCI criteria across different languages and cultures.http://dx.doi.org/10.1155/2015/681976
spellingShingle Angela Federico
Alice Maier
Greta Vianello
Daniela Mapelli
Michela Trentin
Giampietro Zanette
Alessandro Picelli
Marialuisa Gandolfi
Stefano Tamburin
Screening for Mild Cognitive Impairment in Parkinson’s Disease: Comparison of the Italian Versions of Three Neuropsychological Tests
Parkinson's Disease
title Screening for Mild Cognitive Impairment in Parkinson’s Disease: Comparison of the Italian Versions of Three Neuropsychological Tests
title_full Screening for Mild Cognitive Impairment in Parkinson’s Disease: Comparison of the Italian Versions of Three Neuropsychological Tests
title_fullStr Screening for Mild Cognitive Impairment in Parkinson’s Disease: Comparison of the Italian Versions of Three Neuropsychological Tests
title_full_unstemmed Screening for Mild Cognitive Impairment in Parkinson’s Disease: Comparison of the Italian Versions of Three Neuropsychological Tests
title_short Screening for Mild Cognitive Impairment in Parkinson’s Disease: Comparison of the Italian Versions of Three Neuropsychological Tests
title_sort screening for mild cognitive impairment in parkinson s disease comparison of the italian versions of three neuropsychological tests
url http://dx.doi.org/10.1155/2015/681976
work_keys_str_mv AT angelafederico screeningformildcognitiveimpairmentinparkinsonsdiseasecomparisonoftheitalianversionsofthreeneuropsychologicaltests
AT alicemaier screeningformildcognitiveimpairmentinparkinsonsdiseasecomparisonoftheitalianversionsofthreeneuropsychologicaltests
AT gretavianello screeningformildcognitiveimpairmentinparkinsonsdiseasecomparisonoftheitalianversionsofthreeneuropsychologicaltests
AT danielamapelli screeningformildcognitiveimpairmentinparkinsonsdiseasecomparisonoftheitalianversionsofthreeneuropsychologicaltests
AT michelatrentin screeningformildcognitiveimpairmentinparkinsonsdiseasecomparisonoftheitalianversionsofthreeneuropsychologicaltests
AT giampietrozanette screeningformildcognitiveimpairmentinparkinsonsdiseasecomparisonoftheitalianversionsofthreeneuropsychologicaltests
AT alessandropicelli screeningformildcognitiveimpairmentinparkinsonsdiseasecomparisonoftheitalianversionsofthreeneuropsychologicaltests
AT marialuisagandolfi screeningformildcognitiveimpairmentinparkinsonsdiseasecomparisonoftheitalianversionsofthreeneuropsychologicaltests
AT stefanotamburin screeningformildcognitiveimpairmentinparkinsonsdiseasecomparisonoftheitalianversionsofthreeneuropsychologicaltests